559.10 USD
▼-18.24-3.16%
盘后 610.78 0.00%
2026-11-19
市值
$23.69B
市盈率
20.96
EPS
26.53
股息率
—
52 周区间
455.63 – 614.23
成交量
393.73K
Beta
0.48
目标价
687.14
52W 低 455.6352W 高 614.23
价格走势

公司简介

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of tre...

关联新闻